Skip to content

Perception of Children With Visible Untreated and Treated Caries

Perception of Children With Visible Untreated and Treated Caries

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02899273
Acronym
ECC-ET
Enrollment
38
Registered
2016-09-14
Start date
2016-04-01
Completion date
2017-02-21
Last updated
2019-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Keywords

Early Childhood Caries, eye-tracking, children, dentistry, face perception

Brief summary

In Germany about 5 to 20% of children suffer from early childhood caries (ECC). Preceding results of eye-tracking-studies on the perception of patients with unilateral cleft and patients with severe orthognathic malocclusion let us assume that caries and missing teeth might influence the observer's focus. The aim of this study is to test the hypothesis that the faces of patients with ECC and patients with signs of dental treatment (crown, gap etc.) are contemplated differently from and assessed more negatively than healthy patients. Particular attention should be paid to potential differences between the findings of the two observer-groups (medical laypersons/ dental students).

Detailed description

In Germany about 5 to 20% of children suffer from early childhood caries (ECC). Resulting in complications like damages of the permanent teeth, pain and developmental disorder of the affected jaw, ECC might additionally lead to social exclusion. Previous eye-tracking-studies about the perception of patients with unilateral cleft and patients with severe orthognathic malocclusion demonstrated that these variations are transferring the observer's focus from the eyes and nose to the affected region. The aim of this study is to test the hypothesis that the faces of patients with ECC and patients with signs of dental treatment (crown, gap etc.) are contemplated differently from and assessed more negatively than healthy patients. Particular attention should be paid to potential differences between the findings of the two observer-groups (medical laypersons/ dental students).

Interventions

None listed

Sponsors

Stiftung Universität Hildesheim
CollaboratorUNKNOWN
University of Göttingen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* healthy * student of the University of Göttingen or Hildesheim * age ≥ 18 years * people who agreed to participate in the study * right-hander

Exclusion criteria

* missing agreement to participate in the study * missing cooperation, * age \< 18 years * left-hander * wearer of glasses * people with severe systemic diseases, especially states with associated temporary or permanent restriction of immune status * people with severe mental illness who have altered perception or neurophysiological stimulus processing. * people who take regularly or at the time of the study drug or drugs that altered a perception or neurophysiological stimulus processing

Design outcomes

Primary

MeasureTime frameDescription
The first fixation on one of both pictures will be measured3 secboth pictures: a) emotional, b) neutral

Secondary

MeasureTime frameDescription
First fixation of one of three areas of interest will be measured300 msecareas of interest: a) eyes, b) nose, c) mouth
Fixation time and fixation number of areas of interest will be measured2 secareas of interest: a) eyes, b) nose, c) mouth
Are the pictures different in valence, arousal, attractiveness30 minQuestionnaire: 1. How pleasant this stimulus is for you? (9 point scale: 1 negative - 9 positive) 2. How exciting is this stimulus to you? (9 point scale: 1 low - 9 high) 3 How attractive is this appeal to you? (9 point scale: 1 unattractive - 9 attractive) Self-Assessment-Manikin scales

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026